The market size for hormones in dosage, excluding contraceptives and antibiotics, in New Zealand stood at 137.43 million USD in 2023. Year-on-year variations indicate fluctuations, with notable decreases in 2022 by 8.73% but a slight recovery in 2023 with a 0.39% increase. Over the past five years, the compound annual growth rate remained relatively stable around 0.41%, reflecting a fairly steady market despite some yearly variations.

Future trends to watch for include:

Technological advancements in hormone therapy and delivery systems could spur growth.
Increasing awareness and demand for bio-identical and personalized hormone treatments.
Regulatory changes and healthcare policies impacting market dynamics.
Changes in demographics, particularly aging populations, potentially boosting demand.